Remodeling of Resistance Vessels in Essential Hypertension

Hellenic Journal of Cardiology

Volumn 44, Issue 2, 2003, Pages 116-124

  Zervoudaki, Alexandra I ^a,b   Toutouzas, Pavlos K ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Cardiovascular risk; Normalization; Peripheral resistance

Indexed keywords

APOPTOSIS; ARTERIOLE; CAPILLARY PRESSURE; CARDIOVASCULAR RISK; ESSENTIAL HYPERTENSION; HEART OUTPUT; HEART VENTRICLE REMODELING; PATHOPHYSIOLOGY; PROGNOSIS; RESISTANCE BLOOD VESSEL; REVIEW; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

EID: 0842269018     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Oparil S, Weber MA: Hypertension. A companion to Brenner and rector's The Kidney. Saunders Company. Philadelphia 2000: ppl.
2. Lund-Johansson P: Haemodynamics in essential hypertension. Clin Sci 1980; 59: 343-354.
3. Williams SA, Boolell M, Mac Gregor GA, Smaje LH, Wasserman SM, Tooke JE: Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci 1990; 79: 5-8.
4. Le Noble JL, Tangelder GL, Slaaf DW, Van Essen H, Reneman RS, Struyker-Boudier HA: A functional morphometric study of the cremaster muscle microcirculation in young spontaneously hypertensive rats. J Hypertension 1990; 8: 741-748.
5. Sullivan JM, Prewitt RL, Josephs JA: Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983; 5: 844-851.
6. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, et al: Impaired microvascular dilation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-1879.
7. Struijker Boudier HA: The microcirculation and hypertension. J Hypertension 1992; 10 (suppl 7): 147-156.
8. Mulvany MJ: Resistance vessels in hypertension. In Swales J (ed). Textbook of Hypertension. Oxford, Blackwell, 1994; pp: 103-119.
9. Strauer BE: Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure. Am J Cardiol 1990; 65: 34G-41G.
10. Baumbach GL, Heistad DD: Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13: 968-972.
11. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, et al: Vascular remodeling. Letter to the editor. Hypertension 1996; 28: 505-506.
12. Schiffrin EL, Hayoz D: How to assess vascular remodeling in small and medium-sized muscular arteries in humans. Journal of Hypertension 1997; 15: 571-584.
13. Korner PI, Angus JA: Vascular remodeling (commentary). Hypertension 1997; 29: 1065-1066.
14. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, et al: Response. J Hypertens 1997; 15: 334.
15. Skoumas I: Arterial remodeling. Mechanisms and significance. Cardiologica Themata 1995; pp: 539-555.
16. Laurent S, Boutouyrie P: Hypertrophie de la paroi arterielle et rigidite arterielle. Path Biol, 1999; 47 (No 6): 648-655.
17. Mulvany MJ: Determinants of vascular hemodynamic characteristics. Hypertension 1984; 6 (suppl 3): III13-III18.
18. Safar ME, London GM, Asmar R, Frohlich ED: Recent advances on large arteries in hypertension. Hypertension. 1998; 32: 156-161.
19. Gibbons GH, Dzau VJ: The emerging concept of vascular remodeling. New Engl J Medicine 1994; 20: 1431-143810.
20. Intengan HD, Schiffrin EL: Vascular remodeling in hypertension. Hypertension. 2001; 38 (part 2): 581-587.
21. Ueno H, Kannelakis P, Agrotis A, Bobik A: Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension. Hypertension. 2000; 36: 89-96.
22. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, et al: NF-kB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000; 35: 193-201.
23. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ: Small Artery Structure in Hypertension. Dual Processes of Remodeling and growth. Hypertension 1993; 21: 391-394.
24. Intengan HP, Deng LiY, Li JN, Schiffrin EL: Mechanics and Composition of Human Subcutaneous Resistance Arteries in Essential hypertension. Hypertension 1999; 33(part II): 569-574.
25. Safar ME, Frohlich ED: The Arterial System In Hypertension. Hypertension, 1995; 26: 10-14.
26. Tyagi SC: Proteinases and myocardial extracellular matrix turnover. Mol Cell Biochem 1997; 168: 1-12.
27. Falloon BJ, Heargerty AM: In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994; 24: 16-23.
28. Johnson G: On certain points in the anatomy of Bright's disease with contracted kidney. Trans R Med Chir Soc 1868; 51: 57-58.
29. Folkow B, Grimby G, Thulesius O: Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Ascand 1958; 44: 255-272.
30. Aalkjaer C, Heargerty AM, Petersen KK, Swales JD, Mulvany MJ: Evidence for increased media thickness, increased neuronal uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61: 181-186.
31. Izzard AS, Cragoe EJ, Heagerty AM: Intracellular pH in human resistance arteries in essential hypertension. Hypertens 1991; 7: 780-786.
32. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard A, Mulvany MJ: The increased media: lumen ratio in resistance arteries from essential hypertensives is not associated with media hypertrophy or cellular hyperplasia. Blood Vessels 1991; 28: 303.
33. Schiffrin EL, Deng LY, Larochelle P: Blunted effects of endothelin upon small subcutaneous resistance arteries of mild eesential hypertensive patients. J Hypertens 1992; 10: 437-444.
34. Korsgaard N, Aakkjaer C, Heagerty AM, Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; (22): 523-526.
35. Robinson BF, Dobbs RJ, Bayley S: Response of forearm resistance vessels to verapamil and nitroprusside in normotensive and hypertensive men: Evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci 1982; 63: 33-42.
36. Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G: Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Hypertension 1983; 5: 368-374.
37. Schiffrin EL, Deng LY, Sventek P, Day R: Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens 1997; 15: 57-63.
38. Brush JE JR, Faxon DP, Salmon S, Jacobs AK, Ryan TJ: Abnormal endothelium-dependent coronary vasomotion in patients with hypertension. J Am Coll Cardiol 1992; 19: 809-815.
39. Mancini GBJ, Henry GC, Macaya C, O' Neill BJ, Pucillo AL, Carere RG, et al: Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND study. Circulation 1996; 94: 258-265.
40. Panza J, Quyyumi AA, Callahan TS, Epstein SE: Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Cardiol 1993; 21: 1145-1151.
41. O' Rourke M: Mechanical Principles in Arterial Disease. Hypertension 1995; Vol (26), No 1: 2-9.
42. Gribbin B, Pickering TG, Sleight P: Arterial distensibility in normal and hypertensive man. Clin Sci 1979; 56: 413-417.
43. Baumbach GL, Hajdu MA: Mechanics and composition of cerebral arteriols in renal and spotaneously hypertensive rats. Hypertension 1993; 21: 816-826.
44. Hayoz D, Rutschmann B, Perret F, Niederberger M, Tardy Y, Mooser V, et al: Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992; 20: 1-6.
45. Wang N, Butler JP, Ingber DE: Mechanotransduction across the cell surfaces and through the cytoskeleton. Science 1993; 260: 1124-1127.
46. Bezie Y, Lacolley P, Laurent S, Gabella G: Connection of smooth muscle cells to elastic lamellae in aorta of spotaneously hypertensive rats. Hypertension 1998; 32: 166-169.
47. Kappert K, Schmidt G, Doerr G, Wollert-Wulf B, Fleck E, Graf K: Angiotensin II and PDGF-BB Stimulate β1-integrin-mediated Adhesion and spreading in human VSMCs. Hypertension 2000; 35 (part 2): 255-261.
48. Thybo NK, Korsgaard N, Mulvany MJ: Morphology and function of mesenteric resistance arteries in transgenic rats with low renin hypertension. J Hypertens 1992; 10: 1191-1196.
49. Schiffrin EL: Effect of antihypertensive therapy on small artery structure in hypertensive patients (letter). Hypertension 1995; 26: 716-717.
50. Schiffrin EL: Vascular structure in L-NAME-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens 1995; 13: 8117-8121.
51. Ruilope LM, Alcazar JM, Rodicio JL: Renal consequences of hypertension. J Hypertens 1992; 10 (suppl): S85-S90.
52. Mulvany MJ: Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients. Metabolism 1998;Vol 47, No 12 (Suppl 1): 20-23.
53. Schiffrin EL: Vascular protection with newer antihypertensive agents. J. Hypertens 1998; 16 (Suppl5): S25-S29.
54. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE: Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000; 36: 220-225.
55. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25: 474-481.
56. Thurmann PA, Stephens N, Heagerty AM, Kenedi P, Weidinger G, Rietbrok N: Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries. Hypertension 1996; 28: 450-456.
57. Schiffrin EL, Park J-B, Intengan HD, Touyz RM: Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101: 1653-1659.
58. Dahlof B, Hansson L: The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: Different effects of enalapril and hydrochlorthiazide. J Intern Med 1993; 234: 271-279.
59. Sihm I, Schroeder AP, Aalkjaer C, Mulvany MJ, Thygesen K, Lederballe O: Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: A comparison between calcium channel blocker and thiazide-based regimens. Am J Hypertens 1998; 11: 263-271.